Top

Published in:

01-08-2015 | Case Report

Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy

Authors: Arjun Gupta, Samar Harris, Steven Vernino, Harris V. Naina

Published in: Clinical Autonomic Research | Issue 4/2015

Abstract

We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.

Muppidi S, Vernino S (2013) Autoimmune autonomic failure. Handb Clin Neurol 117:321–327CrossRefPubMed

Vernino S, Ermilov LG, Sha L, Szurszewski JH, Low PA, Lennon VA (2004) Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci 24(32):7037–7042PubMedCentralCrossRefPubMed

Gibbons CH, Freeman R (2009) Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci 146(1–2):8–12CrossRefPubMed

Hollenbeck R, Black BK, Peltier AC et al (2011) Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma. Arch Neurol 68(3):372–375PubMedCentralCrossRefPubMed

Imrich R, Vernino S, Eldadah BA, Holmes C, Goldstein DS (2009) Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab. Clin Auton Res 19(4):259–262PubMedCentralCrossRefPubMed

Muppidi S, Scribner M, Gibbons CH, Adams-Huet B, Spaeth EB, Vernino S (2012) A unique manifestation of pupillary fatigue in autoimmune autonomic ganglionopathy. Arch Neurol 69(5):644–648PubMedCentralCrossRefPubMed

Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. New Engl J Med 343(12):847–855CrossRefPubMed

Iodice V, Kimpinski K, Vernino S, Sandroni P, Fealey RD, Low PA (2009) Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology 72(23):2002–2008PubMedCentralCrossRefPubMed

Gibbons CH, Vernino SA, Freeman R (2008) Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol 65(2):213–217CrossRefPubMed

10.

Miles SA, McGratten M (2005) Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma. J Clin Oncol 23(1):247–248CrossRefPubMed

Title: Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy
Authors: Arjun Gupta
Samar Harris
Steven Vernino
Harris V. Naina
Publication date: 01-08-2015
Publisher: Springer Berlin Heidelberg
Published in: Clinical Autonomic Research / Issue 4/2015
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI: https://doi.org/10.1007/s10286-015-0299-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Prediction of compensatory hyperhidrosis with botulinum toxin A and local anesthetic

Long-term continuous positive airway pressure therapy improves cardiac autonomic tone during sleep in patients with obstructive sleep apnea

Parasympathetic reactivation in children: influence of two various modes of exercise

Posterior reversible encephalopathy syndrome as an initial neurological manifestation of primary Sjögren’s syndrome

Successful long-term ambulatory norepinephrine infusions in a patient with pure autonomic failure

Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus